{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:12:08Z","timestamp":1792419128625,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","award":["PIP 11220120100491"],"award-info":[{"award-number":["PIP 11220120100491"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"ANPCyT","doi-asserted-by":"publisher","award":["2016-0549"],"award-info":[{"award-number":["2016-0549"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.lfs.2020.118346","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:09:44Z","timestamp":1598303384000},"page":"118346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Short-term doxorubicin cardiotoxic effects: involvement of cardiac Thyrotropin Releasing Hormone system"],"prefix":"10.1016","volume":"261","author":[{"given":"Ludmila Soledad","family":"Peres Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano Luis","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Aisicovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Eduardo","family":"Toblli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Jos\u00e9","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Silvina","family":"Landa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia In\u00e9s","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2020.118346_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"18","key":"10.1016\/j.lfs.2020.118346_bb0010","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1158\/1078-0432.CCR-14-0821","article-title":"Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage","volume":"20","author":"Nitiss","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2020.118346_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2020.118346_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1254\/jphs.FP0050980","article-title":"Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo","volume":"101","author":"Ueno","year":"2006","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2020.118346_bb0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.lfs.2020.118346_bb0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118346_bb0035","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/ijms18102121","article-title":"Cardiotoxic effects of short-term doxorubicin administration: involvement of connexin 43 in calcium impairment","volume":"18","author":"Pecoraro","year":"2017","journal-title":"Int. J Molecular Science"},{"key":"10.1016\/j.lfs.2020.118346_bb0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcell.2020.00434","article-title":"Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.lfs.2020.118346_bb0045","doi-asserted-by":"crossref","first-page":"H1667","DOI":"10.1152\/ajpheart.00494.2014","article-title":"Thyrotropin-releasing hormone overexpression induces structural changes of the left ventricle in the normal rat heart","volume":"307","author":"Schuman","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118346_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.110.161265","article-title":"Cardiac thyrotropin-releasing hormone mediates left ventricular hypertrophy in spontaneously hypertensive rats","volume":"57","author":"Schuman","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2020.118346_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2018.09.009","article-title":"Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse","volume":"124","author":"Peres Diaz","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2020.118346_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/hyp.74.suppl_1.091","article-title":"Leptin-thyroliberin pathway in left ventricle hypertrophy. Hypertension. AHA Abstract","author":"Aisicovich","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2020.118346_bb0065","first-page":"236","article-title":"C57BL\/6 mice are more appropriate than Balb\/C mice in inducing cardiomyopathy with short-term doxorubicin treatment","volume":"28","author":"Xujie","year":"2012","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.lfs.2020.118346_bb0070","first-page":"1891","article-title":"Polyphenolic fraction of Algerian propolis reverses doxorubicin induced oxidative stress in liver cells and mitochondria","volume":"27","author":"Wided","year":"2014","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2020.118346_bb0075","doi-asserted-by":"crossref","unstructured":"Qinghua Dong, Long Chen1, Qunwei Lu, Sherven Sharma, Lei Li, Sachio Morimoto, Guanyu Wang. Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1expression. Br. J. Pharmacol., DOI:https:\/\/doi.org\/10.1111\/bph.12795 (internet).","DOI":"10.1111\/bph.12795"},{"issue":"2","key":"10.1016\/j.lfs.2020.118346_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MPA.0b013e31818d14a8","article-title":"High levels of thyrotropin-releasing hormone receptors activate programmed cell death in human pancreatic precursors","volume":"38","author":"Mulla","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.lfs.2020.118346_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11357-008-9057-0","article-title":"Wild-derived mouse stocks: an underappreciated tool for aging research","volume":"30","author":"Harper","year":"2008","journal-title":"Age (Dordr.)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:38:35Z","timestamp":1758400715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520310985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":17,"alternative-id":["S0024320520310985"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118346","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term doxorubicin cardiotoxic effects: involvement of cardiac Thyrotropin Releasing Hormone system","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118346"}}